Christopher R. Bowie, Ph.D., C.Psych, is an Associate Professor in the Departments of Psychology and Psychiatry, and a member of the Centre for Neuroscience Studies, at Queen’s University in Kingston, Ontario. He is also a Clinician-Scientist (part-time) at the Centre for Addiction and Mental Health in Toronto, Ontario. His research interests focus on the determining the causes and correlates, and developing treatments for, cognitive deficits in chronic mental disorders such as schizophrenia and major affective disorders. His laboratory at Queen’s is developing new empirical methods to evaluate how symptoms of mental illnesses produce biobehavioural changes in people who encounter them, in order to more clearly delineate the role of stigma and reactive social distancing toward those with mental disorders. After receiving his Ph.D. from Hofstra University and completing an internship at the Clinical Neuroscience Center of Pilgrim Psychiatric Center, he did post-doctoral training with Dr. Barbara Cornblatt where he supervised neuropsychological testing and studied cognitive treatment outcomes, earning a Young Investigator Award from NARSAD. Dr. Bowie took an academic appointment with Dr. Philip Harvey at Mount Sinai School of Medicine and continued to study thefunctional consequences of cognitive impairment in schizophrenia. He was awarded a second NARSAD Young Investigator Award for a study of cognitive remediation in schizophrenia. Currently he is leading multiple trials of cognitive remediation for chronic mental disorders, including an Independent Investigator Award from the Brain and Behavior Foundation to study how to deliver cognitive remediation to the homes of people with serious mental illness. He is the author of over 85 scientific publications and 5 book chapters.